Citations

Dolling, D. I, R. L Goodall, M. Chirara, J. Hakim, P. Nkurunziza, P. Munderi, D. Eram, D. Tumukunde, M. J Spyer, C. F Gilks, P. Kaleebu, D. T Dunn, D. Pillay, P. Kaleebu, D. Pillay, P. Awio, M. Chirara, D. Dunn, D. M Gibbs, C. Gilks, A. Kapaata, M. Katuramur, F. Lyagoba, B. Magambo, K. Mataruka, L. Mugarura, T. Musunga, M. Nabankkema, J. Nkalubo, P. Nkurunziza, C. Parry, V. Robertson, M. Spyer, D. Mulima, D. E Williams, I. Nankya, S. Nassimbwa, E. Ndashimye, E. Nabulime, M. Phiri, K. Mutasa, and S. Mukasa. "The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data." BMC Infectious Diseases 17, no. 1 (2017).

Flood, D., J. A Seiglie, M. Dunn, S. Tschida, M. Theilmann, M. E Marcus, G. Brian, B. Norov, M. T Mayige, M. Singh Gurung, K. K Aryal, D. Labadarios, M. Dorobantu, B. K Silverwood, P. Bovet, J. M Adelin Jorgensen, D. Guwatudde, C. Houehanou, G. Andall-Brereton, S. Quesnel-Crooks, L. Sturua, F. Farzadfar, S. Saeedi Moghaddam, R. Atun, S. Vollmer, T. W Barnighausen, J. I Davies, D. J Wexler, P. Geldsetzer, P. Rohloff, M. Ramirez-Zea, M. Heisler, and J. Manne-Goehler. "The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults." Lancet Healthy Longev 2, no. 6 (2021): e340-e351.

El Bouzidi, K., E. White, J. L Mbisa, C. A Sabin, A. N Phillips, N. Mackie, A. L Pozniak, A. Tostevin, D. Pillay, D. T Dunn, Uk Hiv Drug Resistance Database, and the, U. K. Collaborative H. I. V. Cohort Study Steering Committees, Uk Hiv Drug Resistance Database, and the, U. K. Collaborative H. I. V. Cohort Study Steering Committees. "HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK." J Antimicrob Chemother 71, no. 12 (2016): 3487-3494.

Goodall, R. L, D. T Dunn, P. Nkurunziza, L. Mugarura, T. Pattery, P. Munderi, C. Kityo, C. Gilks, P. Kaleebu, D. Pillay, R. K Gupta, and Dart Virology Group. "Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa." J Antimicrob Chemother 72, no. 5 (2017): 1450-1455.

Price, H., D. Dunn, T. Zachary, T. Vudriko, M. Chirara, C. Kityo, P. Munderi, M. Spyer, J. Hakim, C. Gilks, P. Kaleebu, D. Pillay, R. Gilson, and Dart Virology Group. "Hepatitis B serological markers and plasma DNA concentrations." AIDS 31, no. 8 (2017): 1109-1117.

Smit, E., E. White, D. Clark, D. Churchill, Z. Zhang, S. Collins, D. Pillay, C. Sabin, M. Nelson, A. Winston, S. Jose, A. Tostevin, D. T Dunn, Uk Hiv Drug Resistance Database, and the, U. K. Collaborative H. I. V. Cohort. "An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs." J Antimicrob Chemother 72, no. 7 (2017): 2075-2082.

Tostevin, A., E. White, D. Dunn, S. Croxford, V. Delpech, I. Williams, D. Asboe, A. Pozniak, D. Churchill, A. M Geretti, D. Pillay, C. Sabin, A. Leigh-Brown, E. Smit, and Uk Hiv Drug Resistance Database. "Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom." HIV Med 18, no. 3 (2017): 204-213.

Schultze, A., R. Paredes, C. Sabin, A. N Phillips, D. Pillay, N. Mackie, A. Castagna, D. Chadwick, K. Falconer, A. M Geretti, F. A Post, T. Hill, O. Kirk, A. Pozniak, M. Nelson, A. Tostevin, D. Dunn, J. Lundgren, and A. Cozzi-Lepri. "The association between detected drug resistance mutations and CD4(+) T-cell decline in HIV-positive individuals maintained on a failing treatment regimen." Antivir Ther 23, no. 2 (2018): 105-116.

Marcus, M. E, J. Manne-Goehler, M. Theilmann, F. Farzadfar, S. S Moghaddam, M. Keykhaei, A. Hajebi, S. Tschida, J. M Lemp, K. K Aryal, M. Dunn, C. Houehanou, S. Bahendeka, P. Rohloff, R. Atun, T. W Bärnighausen, P. Geldsetzer, and Ramirez. "Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: A cross-sectional study of nationally representative, individual-level data." The Lancet Global Health 10, no. 3 (2022): e369-e379.